https://www.selleckchem.com/products/CHIR-258.html
42, P= .007), pneumonia (OR= 3.77, P= .001), and periprosthetic fracture (OR= 2.55, P= .001). Rates of the other studied adverse events, including readmissions, were not significantly different between groups. At five years, 94.2% of the CP cohort and 95.2% of the non-CP cohort THAs remained unrevised (no difference by log rank, P= .195). Compared with patients without CP, patients with CP undergoing THA were found to have higher odds of perioperative urinary tract infection, pneumonia, and periprosthetic fracture but not other periope
Like
Comment
Share
